KCP Sugar Q2 FY27: ₹39.3 Cr PAT mostly investment gains, core profit up ~2x YoY
PAT +9258.4% YoY · revenue +16.6% · margins compressing
₹78.35 Cr
+16.6% YoY
₹39.32 Cr
+9258.4% YoY
33.23%
+32.6pp YoY
₹3.47
KCP Sugar's consolidated revenue from operations rose 16.6% YoY to ₹78.35 Cr (essentially flat QoQ, +0.4% versus Q1 FY27's ₹78.03 Cr), while consolidated PAT came in at ₹39.32 Cr (EPS ₹3.47), versus ₹0.42 Cr in Q2 FY26 and ₹46.25 Cr in Q1 FY27 (-15.0% QoQ). Standalone PAT was ₹36.71 Cr (EPS ₹3.24) — close enough to consolidated that there is no material divergence between the two bases this quarter.
Q2 FY-2027 vs prior quarters
The headline YoY profit jump overstates the underlying improvement. Of the ₹39.96 Cr of consolidated other income this quarter, ₹36.95 Cr is a fair-value (mark-to-market) gain on equity investments, per the company's own disclosure, against just ₹2.78 Cr of such gains in the year-ago quarter — this one line alone accounts for almost the entire swing from a near-zero profit base. Stripping it out, adjusted PAT moves from roughly a ₹2.4 Cr loss in Q2 FY26 to roughly a ₹2.4 Cr profit now — a real but modest turnaround, not the ~93x headline growth implies. The genuine operating improvement sits one level down: segment profit before interest/tax and unallocated corporate income rose to ₹9.84 Cr from ₹4.48 Cr a year ago (+119%) and ₹4.47 Cr last quarter (+120%), led by Sugar (₹6.20 Cr vs ₹3.28 Cr YoY, +89%) and the Engineering arm EIMCO-KCP (₹3.28 Cr vs ₹0.83 Cr YoY, +294%); Chemicals stayed loss-making at -₹0.85 Cr, flat YoY. Consolidated NPM (PAT/total income) eased to 33.2% from 34.6% in Q1 FY27 — both quarters' margins are themselves inflated by the same kind of volatile non-operating gains.
The stock went into the print at ₹26.6, up 4% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
No analyst consensus or management guidance on record — company's own Note 1 flags sugar as a seasonal/cyclical business, cautioning against reading quarterly comparisons as trend-indicative
No analyst consensus or brokerage estimates could be found for this quarter (confirmed via search) — there is no public coverage of this micro-cap to benchmark against, so vsStreet is unknown. Management has issued no formal guidance on record either. Separately, the board's results-day letter also disclosed that the EIMCO-KCP manufacturing contract (order dated 11.08.2026) was cut from ₹130 Cr to ₹102 Cr, after ₹28 Cr of SS 2507 reactor-clarifier plate procurement had to be sourced directly because the material wasn't available domestically — a modest negative revision to the order book underpinning the Engineering segment's YoY strength. No separate management press release accompanied this filing to cross-check against the segment commentary.
W1
Whether the ₹36.95 Cr equity investment fair-value gain (94% of other income) sustains or reverses next quarter — it is mark-to-market and non-cash
W2
Core segment profit trajectory into the peak crushing season (Oct-Mar): ₹9.84 Cr in Q2 FY27 vs ₹4.47 Cr in Q1 FY27 and ₹4.48 Cr in Q2 FY26
W3
EIMCO-KCP order execution after the value cut from ₹130 Cr to ₹102 Cr (11.08.2026 contract) — revenue recognition pace into H2 FY27